INO - Inovio Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5248.56M
Enterprise Value 3231.64M
Trailing P/E N/A
Forward P/E 1-2.99
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)33.28
Price/Book (mrq)4.61
Enterprise Value/Revenue 331.01
Enterprise Value/EBITDA 6-2.14

Trading Information

Stock Price History

Beta (3Y Monthly) 2.61
52-Week Change 3-48.78%
S&P500 52-Week Change 32.56%
52 Week High 36.3000
52 Week Low 32.0300
50-Day Moving Average 32.4009
200-Day Moving Average 33.0598

Share Statistics

Avg Vol (3 month) 3776.99k
Avg Vol (10 day) 3637.3k
Shares Outstanding 599.03M
Float 95.32M
% Held by Insiders 16.28%
% Held by Institutions 137.49%
Shares Short (Aug 15, 2019) 411.03M
Short Ratio (Aug 15, 2019) 416.74
Short % of Float (Aug 15, 2019) 411.98%
Short % of Shares Outstanding (Aug 15, 2019) 411.13%
Shares Short (prior month Jul 15, 2019) 411.12M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 24/1
Last Split Date 3Jun 6, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)-1,511.27%

Management Effectiveness

Return on Assets (ttm)-44.94%
Return on Equity (ttm)-139.13%

Income Statement

Revenue (ttm)7.47M
Revenue Per Share (ttm)0.08
Quarterly Revenue Growth (yoy)-99.40%
Gross Profit (ttm)-64.78M
EBITDA -108.04M
Net Income Avi to Common (ttm)-116.58M
Diluted EPS (ttm)-1.2150
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)105.97M
Total Cash Per Share (mrq)1.07
Total Debt (mrq)86.19M
Total Debt/Equity (mrq)152.61
Current Ratio (mrq)4.59
Book Value Per Share (mrq)0.54

Cash Flow Statement

Operating Cash Flow (ttm)-98.33M
Levered Free Cash Flow (ttm)-59.14M